Connection

Raymond DuBois to Neoplasms

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Neoplasms.
Raymond DuBois
Connection Strength
3.002
Neoplasms
  1. The First Lady Presses for Cancer Screening to Get Back On Track. Cancer Prev Res (Phila). 2022 01; 15(1):1-2.
    View in: PubMed
    Score: 0.352
  2. The Urgent Need for Expanded Cancer Screening. Cancer Prev Res (Phila). 2021 12; 14(12):1053-1054.
    View in: PubMed
    Score: 0.347
  3. COVID-19, Cancer Care and Prevention. Cancer Prev Res (Phila). 2020 11; 13(11):889-892.
    View in: PubMed
    Score: 0.322
  4. The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression. Trends Mol Med. 2016 Jan; 22(1):1-3.
    View in: PubMed
    Score: 0.231
  5. Overview of the AACR Clinical and Translational Cancer Research Think Tank meeting. Clin Cancer Res. 2012 Feb 01; 18(3):607-11.
    View in: PubMed
    Score: 0.177
  6. Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res. 2010 Mar 01; 16(5):1384-90.
    View in: PubMed
    Score: 0.155
  7. Eicosanoids and cancer. Nat Rev Cancer. 2010 Mar; 10(3):181-93.
    View in: PubMed
    Score: 0.155
  8. NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med. 2007; 58:239-52.
    View in: PubMed
    Score: 0.124
  9. Measurement of eicosanoids in cancer tissues. Methods Enzymol. 2007; 433:27-50.
    View in: PubMed
    Score: 0.124
  10. Cancer prevention: strategy for the future. Carcinogenesis. 2006 Jun; 27(6):1126-7.
    View in: PubMed
    Score: 0.119
  11. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005 Oct 01; 65(19):8583-6.
    View in: PubMed
    Score: 0.114
  12. Mechanisms of disease: Inflammatory mediators and cancer prevention. Nat Clin Pract Oncol. 2005 Apr; 2(4):202-10.
    View in: PubMed
    Score: 0.110
  13. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005 Jan 10; 23(2):254-66.
    View in: PubMed
    Score: 0.108
  14. Leukotriene A4 signaling, inflammation, and cancer. J Natl Cancer Inst. 2003 Jul 16; 95(14):1028-9.
    View in: PubMed
    Score: 0.098
  15. The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. Expert Opin Emerg Drugs. 2003 May; 8(1):1-7.
    View in: PubMed
    Score: 0.096
  16. The emerging role and potential of COX-2 inhibitors. Clin Adv Hematol Oncol. 2003 Feb; 1(2):97-8.
    View in: PubMed
    Score: 0.095
  17. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002; 53:35-57.
    View in: PubMed
    Score: 0.088
  18. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778.
    View in: PubMed
    Score: 0.071
  19. AACR Cancer Progress Report 2012. Clin Cancer Res. 2012 Nov 01; 18(21 Suppl):S1-100.
    View in: PubMed
    Score: 0.046
  20. Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012 May 15; 118(10):2571-82.
    View in: PubMed
    Score: 0.043
  21. Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):415-6.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.